GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XBUL:SRT3) » Definitions » Cyclically Adjusted PS Ratio

Sartorius AG (XBUL:SRT3) Cyclically Adjusted PS Ratio : 2.81 (As of Jun. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Sartorius AG Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Sartorius AG's current share price is лв179.45. Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was лв63.80. Sartorius AG's Cyclically Adjusted PS Ratio for today is 2.81.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

XBUL:SRT3' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.52   Med: 8.39   Max: 33.28
Current: 4.01

During the past years, Sartorius AG's highest Cyclically Adjusted PS Ratio was 33.28. The lowest was 3.52. And the median was 8.39.

XBUL:SRT3's Cyclically Adjusted PS Ratio is ranked worse than
65.42% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs XBUL:SRT3: 4.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius AG's adjusted revenue per share data for the three months ended in Mar. 2025 was лв23.608. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is лв63.80 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted PS Ratio Chart

Sartorius AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.43 19.33 10.52 7.26 4.10

Sartorius AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.30 4.63 5.08 4.10 3.94

Competitive Comparison of Sartorius AG's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.


;
;

Sartorius AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sartorius AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=179.45/63.80
=2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=23.608/127.7792*127.7792
=23.608

Current CPI (Mar. 2025) = 127.7792.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 7.871 100.417 10.016
201509 8.380 100.417 10.663
201512 7.830 99.717 10.034
201603 8.297 100.017 10.600
201606 25.029 100.717 31.754
201609 9.471 101.017 11.980
201612 8.955 101.217 11.305
201703 8.982 101.417 11.317
201706 9.987 102.117 12.497
201709 10.212 102.717 12.704
201712 11.142 102.617 13.874
201803 11.014 102.917 13.675
201806 11.546 104.017 14.184
201809 11.589 104.718 14.141
201812 11.928 104.217 14.625
201903 12.274 104.217 15.049
201906 12.981 105.718 15.690
201909 12.720 106.018 15.331
201912 13.200 105.818 15.940
202003 14.092 105.718 17.033
202006 15.565 106.618 18.654
202009 18.430 105.818 22.255
202012 20.048 105.518 24.278
202103 23.411 107.518 27.823
202106 25.229 108.486 29.716
202109 26.362 109.435 30.781
202112 26.101 110.384 30.214
202203 28.205 113.968 31.623
202206 27.379 115.760 30.222
202209 26.067 118.818 28.033
202212 28.170 119.345 30.161
202303 24.205 122.402 25.268
202306 22.599 123.140 23.450
202309 21.669 124.195 22.294
202312 23.210 123.773 23.961
202403 21.925 125.038 22.406
202406 22.584 125.882 22.924
202409 21.861 126.198 22.135
202412 47.530 127.041 47.806
202503 23.608 127.779 23.608

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (XBUL:SRT3) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sartorius AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.

Sartorius AG Headlines

No Headlines